↓ Skip to main content

Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, February 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
37 Mendeley